StonvexLoading…
StonvexStonvexStonvexCore line items from AOSL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $508.56M | $344.76M | $182.50M | $696.16M |
Operating Income | $-32.21M | $-18.15M | $-4.58M | $-28.44M |
Net Income | $-29.20M | $-15.41M | $-2.12M | $-96.98M |
EPS (Diluted) | $-0.98 | $-0.52 | $-0.07 | $-3.30 |
Total Assets | $976.41M | $1.00B | $1.04B | $1.03B |
Total Liabilities | $176.23M | $183.53M | $203.44M | $211.97M |
Cash & Equivalents | $190.25M | $196.34M | $223.51M | $153.08M |
Free Cash Flow OCF − CapEx | $-43.13M | $-22.67M | $420.00K | $-7.51M |
Shares Outstanding | 29.92M | 29.58M | 30.05M | 30.01M |